Does early imatinib-induced myelosuppression predict hematologic responses in patients with advanced-phase chronic myeloid leukemia?
- PMID: 14615462
- DOI: 10.1200/JCO.2003.99.209
Does early imatinib-induced myelosuppression predict hematologic responses in patients with advanced-phase chronic myeloid leukemia?
Comment on
-
Practical management of patients with chronic myeloid leukemia receiving imatinib.J Clin Oncol. 2003 Apr 15;21(8):1637-47. doi: 10.1200/JCO.2003.11.143. Epub 2003 Mar 13. J Clin Oncol. 2003. PMID: 12668652 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
